Skip to content

Nanoviricides, Inc.

NNVC· NYSECore metricsCIK 1379006

Pharmaceutical preparations552 peers

Last sale
Nov 6, 2026 · +0.38%
Market cap
$33.73M
25.55M shares
Filings
557
$0.00
Q1 2027
-$5.74M
Q1 2027N/M FY26 yoy
-$5.77M
Q1 2027N/M FY26 yoy
-$7.78M
FY 2026derivedN/M FY26 yoy
-$0.23
Q1 2027N/M FY26 yoy
$2.58M
Q1 2027+79.3% FY26 yoy
$33.73M
—
—
5.3×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$1.3233.33%$0.66past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2026
$0.000FY 2023FY 2024FY 2025FY 2026
PeriodEndedValueKindSource trail
FY 20262026-06-30$0reported
FY 20252025-06-30$0reported
FY 20242024-06-30$0reported
FY 20232023-06-30$0reported

Pharmaceutical preparations

Nanoviricides, Inc. is the 357th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Nanoviricides, Inc. · CIK 1379006 · Engraved from SEC EDGAR